During the past decade, Vanderbilt University Oncology Pharmacy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt University Oncology Pharmacy" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt University Oncology Pharmacy" are "Advanced Cancer" (1 trials), "Non Squamous Lung Cancer" (1 trials), "Renal Cell Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Vanderbilt University Oncology Pharmacy" in a lesser frequency.

Most popular intervention types in "Vanderbilt University Oncology Pharmacy" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Avelumab (MSB0010718C)" (1 trials), "Axitinib" (1 trials), "Axitinib (AG-013736)" (1 trials) and "CMP-001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt University Oncology Pharmacy" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Vanderbilt University Oncology Pharmacy". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vanderbilt University Oncology Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt University Oncology Pharmacy, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".